Down-regulation of hypoxia-inducible factor-1α by hyperbaric oxygen attenuates the severity of acute pancreatitis in rats

Pancreas

Volumn 38, Issue 5, 2009, Pages 515-522

  Bai, Xuewei ^a   Sun, Bei ^a   Pan, Shangha ^a   Jiang, Hongchi ^a   Wang, Feng ^a   Krissansen, Geoffrey W ^b   Sun, Xueying ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Acute pancreatitis; Hyperbaric oxygen; Hypoxia; Hypoxia inducible factor 1; Vascular endothelial growth factor

Indexed keywords

AMYLASE; DEXTROMETHORPHAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTATE DEHYDROGENASE; MYELOPEROXIDASE; TAUROCHOLIC ACID; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN SATURATION; ARTERY; ARTICLE; BLOOD PH; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; ENZYME ACTIVITY; HISTOPATHOLOGY; HYPERBARIC OXYGEN; IMMUNOHISTOCHEMISTRY; INTERFERON PRODUCTION; MALE; NONHUMAN; ORGAN WEIGHT; OXYGEN TENSION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SERUM; UPREGULATION; VEIN; WESTERN BLOTTING; WISTAR RAT;

ACUTE DISEASE; ANIMALS; BLOTTING, WESTERN; DOWN-REGULATION; HYPERBARIC OXYGENATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; PANCREATITIS; PEROXIDASE; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; TAUROCHOLIC ACID; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67651100674     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31819cac24     Document Type: Article

References (44)

1. Toouli J, Brooke-Smith M, Bassi C, et al. Guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol. 2002; 17(suppl):S15-S39.
2. Steinberg W, Tenner S. Medical progress: acute pancreatitis. N Engl J Med. 1994;330:1198-1210.
3. Mitchell RM, Byrne MF, Baillie J. Pancreatitis. Lancet. 2003;361:1447-1455.
4. Perez A, Whang EE, Brooks DC, et al. Is severity of necrotizing pancreatitis increased in extended necrosis and infected necrosis? Pancreas. 2002;25:229-233.
5. Furukawa M, Kimura T, Sumii T, et al. Role of local pancreatic blood flow in development of hemorrhagic pancreatitis induced by stress in rats. Pancreas. 1993;8:499-505. (Pubitemid 23183295)
6. Kinnala PJ, Kuttila KT, Gronroos JM, et al. Pancreatic tissue perfusion in experimental acute pancreatitis. Eur J Surg. 2001;167: 689-694. (Pubitemid 33035852)
7. Foitzik T, Eibl G, Hotz B, et al. Persistent multiple organ microcirculatory disorders in severe acute pancreatitis: experimental findings and clinical implications. Dig Dis Sci. 2002;47:130-138. (Pubitemid 34075029)
8. Menger MD, Plusczyk T, Vollmar B. Microcirculatory derangements in acute pancreatitis. J Hepatobiliary Pancreat Surg. 2001;8: 187-194.
9. Cuthbertson CM, Christophi C. Potential effects of hyperbaric oxygen therapy in acute pancreatitis. ANZ J Surg. 2006;76: 625-630. (Pubitemid 43894117)
10. Cuthbertson CM, Su KH, Muralidharan V, et al. Hyperbaric oxygen improves capillary morphology in severe acute pancreatitis. Pancreas. 2008;36:70-75.
11. Christophi C, Millar I, Nikfarjam M, et al. Hyperbaric oxygen therapy for severe acute pancreatitis. J Gastroenterol Hepatol. 2007;22:2042-2046. (Pubitemid 47525042)
12. Nikfarjam M, Cuthbertson CM, Malcontenti-Wilson C, et al. Hyperbaric oxygen therapy reduces severity and improves survival in severe acute pancreatitis. J Gastrointest Surg. 2007;11: 1008-1015.
13. Festugato M, Coelho CP, Fiedler G, et al. Hyperbaric oxygen therapy effects on tissue lesions in acute pancreatitis: experimental study in rats. JOP. 2008;9:275-282. (Pubitemid 351864887)
14. Chen RM, Chen MF. The effects of hyperbaric oxygenation in rat severe acute pancreatitis: pattern of cytokine evolution [abstract]. Gastroenterology. 1999;116:A1304.
15. Isik AT, Mas MR, Comert B, et al. The effect of combination therapy of hyperbaric oxygen, meropenem, and selective nitric oxide synthase inhibitor in experimental acute pancreatitis. Pancreas. 2004;28:53-57. (Pubitemid 38032245)
16. Yasar M, Yildiz S, Mas R, et al. The effect of hyperbaric oxygen treatment on oxidative stress in experimental acute necrotizing pancreatitis. Physiol Res. 2003;52:111-116. (Pubitemid 36356268)
17. Semenza GL. Life with oxygen. Science. 2007;318:62-64.
18. Fulda S, Debatin KM. HIF-1-regulated glucose metabolism: a key to apoptosis resistance? Cell Cycle. 2007;6:790-792.
19. Semenza GL, Jiang BH, Leung SW, et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem. 1996;271:32529-32537. (Pubitemid 27008669)
20. Jiang BH, Rue E, Wang GL, et al. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem. 1996;271:17771-17778. (Pubitemid 26250751)
21. Unruh A, Ressel A, Mohamed HG, et al. The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene. 2003;22:3213-3220. (Pubitemid 36712933)
22. Cramer T, Yamanishi Y, Clausen BE, et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell. 2003;112:645-657. (Pubitemid 36331777)
23. Cuthbertson CM, Christophi C. Disturbances of the microcirculation in acute pancreatitis. Br J Surg. 2006;93:518-530.
24. Gomez G, Englander EW, Wang G, et al. Increased expression of hypoxia-inducible factor-1alpha, p48, and the Notch signaling cascade during acute pancreatitis in mice. Pancreas. 2004;28:58-64. (Pubitemid 38032246)
25. Schmidt J, Rattner DW, Lewandrowski K, et al. A better model of acute pancreatitis for evaluating therapy. Ann Surg. 1992;215:44-56.
26. Ma L, Luo L, Qiao H, et al. Vasostatin synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas. J Hepatol. 2006;46:98-106.
27. Jiang H, Meng F, Li W, et al. Splenectomy ameliorates acute multiple organ damage induced by liver warm ischemia reperfusion in rats. Surgery. 2007;141:32-40. (Pubitemid 44918074)
28. Sun L, Marti HH, Veltkamp R. Hyperbaric oxygen reduces tissue hypoxia and hypoxia-inducible factor-1 alpha expression in focal cerebral ischemia. Stroke. 2008;39:1000-1006. (Pubitemid 351619543)
29. Gill AL, Bell CN. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM. 2004;97:385-395.
30. Marx RE, Ehler WJ, Tayapongsak P, et al. Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am J Surg. 1990;160:519-524. (Pubitemid 20375616)
31. Niinikoski JH. Clinical hyperbaric oxygen therapy, wound perfusion, and transcutaneous oximetry. World J Surg. 2004;28:307-311. (Pubitemid 38375534)
32. Bean J. Effects of oxygen at increased pressure. Physiol Rev. 1945;25:1.
33. Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med. 1996;334:1642-1648.
34. Dubois L, Landuyt W, Haustermans K, et al. Evaluation of hypoxia in an experimental rat tumour model by [(18)F] fluoromisonidazole PET and immunohistochemistry. Br J Cancer. 2004;91:1947-1954.
35. Weis SM, Cheresh DA. Pathophysiological consequences of VEGF-induced vascular permeability. Nature. 2005;437:497-504.
36. Zinkernagel AS, Johnson RS, Nizet V. Hypoxia inducible factor (HIF) function in innate immunity and infection. J Mol Med. 2007;85:1339-1346. (Pubitemid 350234101)
37. Day AL, Wick E, Jordan TH, et al. Neutral endopeptidase determines the severity of pancreatitis-associated lung injury. J Surg Res. 2005;128:21-27. (Pubitemid 41188205)
38. Malleo G, Mazzon E, Siriwardena AK, et al. TNF-alpha as a therapeutic target in acute pancreatitisVlessons from experimental models. Sci World J. 2007;7:431-448. (Pubitemid 46536397)
39. Tracey KJ, Fong Y, Hesse DG, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 1987;330:662-664. (Pubitemid 18005583)
40. Liu FQ, Liu Y, Lui VC, et al. Hypoxia modulates lipopolysaccharide induced TNF-alpha expression in murine macrophages. Exp Cell Res. 2008;314:1327-1336.
41. Peyssonnaux C, Cejudo-Martin P, Doedens A, et al. Cutting edge: essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide- induced sepsis. J Immunol. 2007;178:7516-7519. (Pubitemid 46898018)
42. Albina JE, Mastrofrancesco B, Vessella JA, et al. HIF-1 expression in healing wounds: HIF-1α induction in primary inflammatory cells by TNF-α. Am J Physiol Cell Physiol. 2001;281:C1971-C1977. (Pubitemid 33775043)
43. Sandau KB, Zhou J, Kietzmann T, et al. Regulation of the hypoxiainducible factor 1α by the inflammatory mediators nitric oxide and tumor necrosis factor-α in contrast to desferroxamine and phenylarsine oxide. J Biol Chem. 2001;276:39805-39811. (Pubitemid 37391388)
44. Jung Y, Isaacs JS, Lee S, et al. Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation. Biochem J. 2003;370:1011-1017. (Pubitemid 36399095)